Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Covetrus stock

CVET
US22304C1009
A2PBX0

Price

20.99
Today +/-
+0
Today %
+0 %

Covetrus stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Covetrus stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Covetrus stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Covetrus stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Covetrus's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Covetrus Stock Price History

DateCovetrus Price
10/14/202220.99 undefined
10/13/202220.99 undefined

Covetrus Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Covetrus, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Covetrus from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Covetrus’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Covetrus. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Covetrus’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Covetrus’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Covetrus’s growth potential.

Covetrus Revenue, EBIT and net profit per share

DateCovetrus RevenueCovetrus EBITCovetrus Net Income
2026e6.14 B undefined372.89 M undefined248.53 M undefined
2025e5.79 B undefined332.25 M undefined219.54 M undefined
2024e5.56 B undefined301.96 M undefined197.81 M undefined
2023e5.24 B undefined274.14 M undefined175.8 M undefined
2022e4.93 B undefined239.81 M undefined154.36 M undefined
20214.58 B undefined-23 M undefined-54 M undefined
20204.34 B undefined-69 M undefined-19 M undefined
20193.98 B undefined-59 M undefined-980 M undefined
20183.78 B undefined145.6 M undefined100.9 M undefined
20173.58 B undefined135.3 M undefined64.4 M undefined
20163.35 B undefined131.1 M undefined70.3 M undefined
20152.98 B undefined112.1 M undefined60.3 M undefined

Covetrus Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20152016201720182019202020212022e2023e2024e2025e2026e
2.983.353.583.783.984.344.584.935.245.565.796.14
-12.596.745.565.249.135.447.806.316.034.106.17
17.8018.4618.2218.1018.8418.3918.7517.4016.3615.4314.8313.96
53061965268474979885800000
607064100-980-19-54154175197219248
-16.67-8.5756.25-1,080.00-98.06184.21-385.1913.6412.5711.1713.24
111.2111.2111.2111.310711813700000
------------
Details

Keystats

ⓘ

Revenue and Growth

The Covetrus Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Covetrus is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
201620172018201920202021
           
19.716.723.3130290183
358.9427.9430.8426507480
64.875.649.2676775
473.7534.7564.2636530583
15.222.119.1813730
0.931.081.091.341.431.35
50.964.668.5177233281
20.62321.7459049
000000
246.4252.9208.2643555439
0.650.760.751.151.191.25
47.839.998.30043
1.011.141.152.022.072.06
1.952.222.233.363.53.41
           
0001,0001,0001,000
0002.342.632.67
1.181.31.58-1-1.03-1.08
-100.4-42-82.2-86-66-79
000000
1.081.261.491.251.541.51
341.2375.8441.5520405442
35.533.436.96389151
88.499.293.518419573
000000
1.13.20.762232
466.2511.6572.6829691698
0.030.020.021.131.071.01
15.218.916.4482813
36.939.234.694136151
0.080.080.071.271.231.18
0.540.590.652.11.921.88
1.621.852.143.353.463.39
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Covetrus provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Covetrus's financial health and stability.

Assets

Covetrus's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Covetrus must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Covetrus after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Covetrus's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2015201620172018201920202021
8510092107-1,022-17-54
50555964155166171
-4-66-4-25-32-22
-39-50-56-15-5-66-92
45761,000299
0000474022
56711182427
9610410815710353102
-9-12-20-22-39-58-60
-115-122-128-29-65-5-140
-106-110-107-7-2653-80
0000000
000-01.18-0.12-0.03
000052600
282015-11966104-66
282015-11758-28-36
0000-1,174-60
80-36107160-107
86.892.187.5135.964-542
0000000

Covetrus stock margins

The Covetrus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Covetrus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Covetrus.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Covetrus's sales revenue. A higher gross margin percentage indicates that the Covetrus retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Covetrus's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Covetrus's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Covetrus's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Covetrus. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Covetrus's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Covetrus Margin History

Covetrus Gross marginCovetrus Profit marginCovetrus EBIT marginCovetrus Profit margin
2026e18.75 %6.07 %4.04 %
2025e18.75 %5.74 %3.79 %
2024e18.75 %5.43 %3.56 %
2023e18.75 %5.23 %3.35 %
2022e18.75 %4.86 %3.13 %
202118.75 %-0.5 %-1.18 %
202018.39 %-1.59 %-0.44 %
201918.84 %-1.48 %-24.65 %
201818.11 %3.85 %2.67 %
201718.21 %3.78 %1.8 %
201618.49 %3.91 %2.1 %
201517.8 %3.76 %2.02 %

Covetrus Stock Sales Revenue, EBIT, Earnings per Share

The Covetrus earnings per share therefore indicates how much revenue Covetrus has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Covetrus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Covetrus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Covetrus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Covetrus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Covetrus Revenue, EBIT and net profit per share

DateCovetrus Sales per ShareCovetrus EBIT per shareCovetrus Earnings per Share
2026e43.85 undefined0 undefined1.77 undefined
2025e41.3 undefined0 undefined1.57 undefined
2024e39.68 undefined0 undefined1.41 undefined
2023e37.42 undefined0 undefined1.25 undefined
2022e35.2 undefined0 undefined1.1 undefined
202133.39 undefined-0.17 undefined-0.39 undefined
202036.77 undefined-0.58 undefined-0.16 undefined
201937.16 undefined-0.55 undefined-9.16 undefined
201833.94 undefined1.31 undefined0.91 undefined
201732.19 undefined1.22 undefined0.58 undefined
201630.15 undefined1.18 undefined0.63 undefined
201526.78 undefined1.01 undefined0.54 undefined

Covetrus business model

Covetrus Inc is a global company specializing in providing services and products for veterinarians, animal clinics, and pet owners. It was formed in 2019 through a merger between the animal health divisions of Henry Schein and Vets First Choice. Covetrus traces its history back to 1856 when Henry Schein was founded as a small wholesale drug company. Over the years, the company expanded into new industries and markets. In the 2000s, Henry Schein began serving the animal health industry and established Vets First Choice in 2010 to offer a wider range of services and products to veterinarians and animal clinics. With the merger of Vets First Choice and Henry Schein's animal health division in 2019, Covetrus was created as a company with a broad spectrum of products and services for the animal health industry. Covetrus is headquartered in Portland, Maine, USA, and operates in over 25 countries. Its business model is based on providing services and products for veterinarians, animal clinics, and pet owners. The company is divided into several business segments, including diagnostics, pharmaceuticals, and consumables. In the diagnostics area, Covetrus offers a wide range of laboratory diagnostic services for veterinarians, including blood tests, imaging, fecal tests, and genetic tests. These test results help veterinarians diagnose and treat diseases in pets. In the pharmaceutical area, Covetrus offers veterinary medicines for various types of pets, including dogs, cats, and horses. These medicines are developed by leading pharmaceutical companies, and Covetrus provides veterinarians with a reliable supply chain for these products. The most recent business segment of Covetrus is the consumables area. Here, the company offers a wide range of products for veterinarians and animal clinics, including medical devices, surgical instruments, consumables for routine examinations, and more. In addition to these three main business segments, Covetrus also offers a variety of services, including practice management systems, training for veterinarians and animal clinics, financial services, and more. These services are designed to help veterinarians and animal clinics optimize their operations and improve their quality. The company has also developed a mobile application called 'Covetrus Connect' which provides veterinarians and animal clinics with an easier way to access products and services, place orders, and manage their operations. Overall, Covetrus is an innovative and rapidly growing company in the animal health industry. With a wide range of products and services tailored to the needs of veterinarians, animal clinics, and pet owners, the company is well-positioned to continue growing in this emerging market. Covetrus is one of the most popular companies on Eulerpool.com.

Covetrus SWOT Analysis

Strengths

1. Market Leader: Covetrus Inc is one of the leading companies in the animal health technology and services industry, enjoying a significant market share.

2. Global Presence: The company operates in multiple countries, allowing it to reach a wide customer base worldwide.

Weaknesses

1. Dependency on Veterinary Practices: Covetrus Inc heavily relies on partnerships with veterinary practices for its revenue, making it susceptible to changes in their business models or declining demand.

2. Limited Product Portfolio: The company's product offerings are primarily focused on animal health technology and services, which may restrict its growth potential compared to companies with more diversified portfolios.

Opportunities

1. Growing Pet Industry: The increasing pet ownership and demand for related products and services present an opportunity for Covetrus Inc to expand its customer base and revenue.

2. Technological Advancements: Embracing emerging technologies in the animal health sector, such as telemedicine and digital healthcare solutions, can help Covetrus Inc enhance its offerings and stay ahead of competitors.

Threats

1. Intense Competition: The animal health technology and services industry is competitive, with the presence of established players and new entrants. Covetrus Inc needs to continually innovate and differentiate itself to maintain a competitive edge.

2. Regulatory Challenges: Compliance with regulatory requirements in various markets can pose challenges for Covetrus Inc, requiring significant investments and resources.

Covetrus Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Covetrus Revenue by Segment

Segmente202120202019
North America2.72 B USD2.38 B USD2.11 B USD
Europe1.41 B USD1.57 B USD1.51 B USD
APAC & Emerging Markets461 M USD402 M USD368 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Covetrus Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Covetrus historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Covetrus shares outstanding

The number of shares was Covetrus in 2023 — This indicates how many shares 137 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Covetrus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Covetrus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Covetrus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Covetrus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Covetrus.

Covetrus shareholders

%
Name
Stocks
Change
Date
24.07335 % Clayton, Dubilier & Rice, LLC33,732,30061,7596/30/2022
11.28664 % BlackRock Institutional Trust Company, N.A.15,815,175405,4926/30/2022
8.31956 % The Vanguard Group, Inc.11,657,622108,1606/30/2022
5.97540 % Wellington Management Company, LLP8,372,90815,4126/30/2022
2.76787 % State Street Global Advisors (US)3,878,41934,7946/30/2022
2.20138 % Dimensional Fund Advisors, L.P.3,084,639583,4996/30/2022
2.08478 % Pentwater Capital Management LP2,921,2612,921,2616/30/2022
2.06713 % Balyasny Asset Management LP2,896,5252,896,5256/30/2022
1.99909 % Freshford Capital Management, LLC2,801,188-1,080,0886/30/2022
1.37672 % Geode Capital Management, L.L.C.1,929,09622,2096/30/2022
1
2
3
4
5
...
10

Covetrus Executives and Management Board

Mr. Benjamin Wolin

(47)
Covetrus President, Chief Executive Officer, Director (since 2019)
Compensation 6.52 M

Mr. Matthew Malenfant

(60)
Covetrus Chief Commercial Officer
Compensation 2.73 M

Mr. Matthew Foulston

(58)
Covetrus Chief Financial Officer, Executive Vice President
Compensation 2.52 M

Ms. Georgina Wraight

(47)
Covetrus Executive Vice President, President - Global Technology Solutions
Compensation 1.76 M

Mr. Dustin Finer

(52)
Covetrus Chief Administrative Officer
Compensation 1.55 M
1
2
3
4
...
5

Most common questions regarding Covetrus

What values and corporate philosophy does Covetrus represent?

Covetrus Inc represents a set of core values and a strong corporate philosophy. The company is committed to providing comprehensive animal healthcare solutions with compassion and innovation. Covetrus aims to improve the well-being and longevity of animals, while supporting the success of veterinary professionals through a client-centric approach. With a focus on excellence, collaboration, and integrity, Covetrus ensures the delivery of high-quality products, services, and technology solutions to meet the evolving needs of the animal healthcare industry. The company's dedication to ethical practices and sustainability further exemplifies their commitment to both their customers and the global community.

In which countries and regions is Covetrus primarily present?

Covetrus Inc is primarily present in multiple countries and regions worldwide. The company has a global reach, with a strong presence in North America, Europe, and Asia. Covetrus serves customers in the United States, Canada, the United Kingdom, Germany, France, Italy, Spain, the Netherlands, China, and several other countries. With its expansive international footprint, Covetrus aims to meet the diverse needs of veterinary practices and animal health professionals across different markets and geographies.

What significant milestones has the company Covetrus achieved?

Covetrus Inc, a leading global animal-health technology and services company, has achieved significant milestones since its establishment. The company has successfully expanded its product portfolio, offering a comprehensive range of veterinary supplies, medications, and clinical services to support animal healthcare providers. Covetrus Inc has also implemented innovative technologies to enhance efficiency and streamline operations, driving growth and improving customer satisfaction. Additionally, the company has made strategic acquisitions and partnerships to strengthen its global presence and expand its offerings in the animal health industry. Covetrus Inc continues to demonstrate its commitment to advancing animal healthcare through continuous innovation and strategic initiatives.

What is the history and background of the company Covetrus?

Covetrus Inc is a leading global animal health technology and services company. It was formed in 2019 as a result of a merger between Vets First Choice and Henry Schein Animal Health. With a rich history, Covetrus has roots that date back to the mid-1990s when Vets First Choice was first established. Over the years, the company has evolved, expanded its offerings, and developed innovative solutions to support veterinary professionals and animal health. Covetrus now operates in more than 25 countries, serving over 100,000 customers worldwide. Its comprehensive portfolio includes practice management software, pharmacy services, online pharmacy platforms, and supply chain solutions, all aimed at improving the health and well-being of animals.

Who are the main competitors of Covetrus in the market?

The main competitors of Covetrus Inc in the market include IDEXX Laboratories, Inc., Patterson Companies, Inc., and Henry Schein, Inc.

In which industries is Covetrus primarily active?

Covetrus Inc is primarily active in the animal health industry. With its comprehensive range of products, technologies, and services, Covetrus aims to improve the health and well-being of animals worldwide. Serving both veterinary practices and pet owners, Covetrus offers innovative solutions for pharmaceuticals, digital imaging, practice management software, and more. As a global leader in animal health, Covetrus leverages its expertise to provide high-quality care and support for companion animals, livestock, and other creatures.

What is the business model of Covetrus?

The business model of Covetrus Inc is to provide technology-enabled services and solutions for the veterinary market. As a leading global animal health technology and services company, Covetrus offers a comprehensive suite of software, pharmacy, and supply chain solutions for veterinary practices, clinics, and hospitals. By harnessing the power of technology, Covetrus aims to enhance patient care, improve practice efficiency, and streamline the veterinary supply chain. With a strong focus on innovation and customer-centric offerings, Covetrus continues to empower veterinary professionals with advanced tools and resources to deliver quality care to animals worldwide.

What is the P/E ratio of Covetrus 2024?

The Covetrus P/E ratio is 14.54.

What is the P/S ratio of Covetrus 2024?

The Covetrus P/S ratio is 0.52.

What is the Quality Investing of Covetrus?

The Quality Investing for Covetrus is 3/10.

What is the revenue of Covetrus 2024?

The expected Covetrus revenue is 5.56 B USD.

How high is the profit of Covetrus 2024?

The expected Covetrus profit is 197.81 M USD.

What is the business model of Covetrus

Covetrus Inc. is a leading company in the animal health industry, offering a wide range of solutions and products used by veterinarians, animal clinics, and other companies in the animal health sector. The company was founded in February 2019 when the two companies Vets First Choice and Henry Schein Animal Health merged. Covetrus Inc. provides its customers with a comprehensive platform that allows them to run their business more effectively, increase their revenue, and better serve their customers. The platform includes a variety of tools and services, including e-commerce solutions, practice management software, customized marketing solutions, veterinary products, and more. E-commerce solutions: Covetrus Inc. provides merchants and veterinarians with a platform that enables them to sell their goods online while better serving their customers. The platform is fully customizable and can be tailored to the specific requirements of each merchant. Practice management software: Covetrus Inc. offers a wide range of solutions to help veterinarians and animal clinics operate their practice more effectively. This includes solutions such as simplifying appointment scheduling, billing, invoicing, patient and inventory management, and a variety of other tools to optimize workflow in the practice. Marketing solutions: Covetrus Inc. works closely with its customers to develop customized marketing solutions that are specifically tailored to the needs and requirements of each company. This includes solutions such as developing and implementing advertising campaigns, emails, social media marketing, and more. Veterinary products: Covetrus Inc. offers a wide range of veterinary products used by veterinarians and animal clinics. The products range from diagnostic tests to surgical instruments, providing top quality and reliability. Covetrus Inc. operates in various regions of the world, including North America, Europe, Asia, and Australasia. The company pursues a strategy of continuous improvement and innovation to constantly provide its customers with new and improved solutions. It works closely with its customers to ensure that its products and services meet their requirements and needs. Overall, Covetrus Inc. is a leading company in the animal health industry that offers its customers a wide range of solutions and products. From e-commerce solutions to veterinary products, Covetrus Inc. has an industry-leading platform that allows its customers to run their business more effectively while better serving their customers.

What is the Covetrus dividend?

Covetrus pays a dividend of 0 USD distributed over payouts per year.

How often does Covetrus pay dividends?

The dividend cannot currently be calculated for Covetrus or the company does not pay out a dividend.

What is the Covetrus ISIN?

The ISIN of Covetrus is US22304C1009.

What is the Covetrus WKN?

The WKN of Covetrus is A2PBX0.

What is the Covetrus ticker?

The ticker of Covetrus is CVET.

How much dividend does Covetrus pay?

Over the past 12 months, Covetrus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Covetrus is expected to pay a dividend of 0 USD.

What is the dividend yield of Covetrus?

The current dividend yield of Covetrus is .

When does Covetrus pay dividends?

Covetrus pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Covetrus?

Covetrus paid dividends every year for the past 0 years.

What is the dividend of Covetrus?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Covetrus located?

Covetrus is assigned to the 'Health' sector.

Wann musste ich die Aktien von Covetrus kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Covetrus from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did Covetrus pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of Covetrus in the year 2023?

In the year 2023, Covetrus distributed 0 USD as dividends.

In which currency does Covetrus pay out the dividend?

The dividends of Covetrus are distributed in USD.

All fundamentals about Covetrus

Our stock analysis for Covetrus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Covetrus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.